Significance of expression of cyclooxygenase-2 and lung resistance protein in gastric cancer

World Chinese Journal of Digestology

Volumn 17, Issue 22, 2009, Pages 2312-2316

  Wang, Jun Xian ^a   Zhang, Kai Guang ^a   Wang, Qiao Min ^a   Wu, Zheng Xiang ^a   Chen, Ke ^a   Wang, Xiao Qiu ^a   Ding, Min ^a   Fang, Xue Song ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Correlation; Cyclooxygenase 2; Gastric carcinoma; Immunohistochemistry; Lung resistance protein

Indexed keywords

CYCLOOXYGENASE 2; LUNG RESISTANCE PROTEIN;

ARTICLE; CANCER INVASION; CANCER RESISTANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION;

EID: 70349638722     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i22.2312     Document Type: Article

References (15)

1. Keller JJ, Giardiello FM. Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther 2003; 2: S140-S149
2. Pérez-Tomás R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006; 13: 1859-1876
3. Sun J, He ZG, Cheng G, Wang SJ, Hao XH, Zou MJ. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit 2004; 10: RA5-RA14 (Pubitemid 38176014)
4. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC, Scheper RJ. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995; 1: 578-582
5. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein- mediated multidrug resistance. Cancer Res 1993; 53: 1475-1479 (Pubitemid 23113213)
6. Ikeda K, Oka M, Narasaki F, Fukuda M, Nakamura T, Nagashima S, Terashi K, Sato S, Kawabata S, Mizuta Y, Soda H, Kohno S. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. Anticancer Res 1998; 18: 3077-3080 (Pubitemid 28388819)
7. Fan K, Fan D, Cheng LF, Li C. Expression of multidrug resistance-related markers in gastric cancer. Anticancer Res 2000; 20: 4809-4814 (Pubitemid 32127734)
8. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S- transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Invest 2008; 26: 344-351 (Pubitemid 351601390)
9. Mao XY, Wang XG, Lv XJ, Xu L, Han CB. COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray. World J Gastroenterol 2007; 13: 3466-3471 (Pubitemid 47162020)
10. Samaka RM, Abdou AG, Abd El-Wahed MM, Kandil MA, El-Kady NM. Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters. J Egypt Natl Canc Inst 2006; 18: 363-374
11. Saikawa Y, Sugiura T, Toriumi F, Kubota T, Suganuma K, Isshiki S, Otani Y, Kumai K, Kitajima M. Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15. Anticancer Res 2004; 24: 2723-2728 (Pubitemid 39407149)
12. Surowiak P, Pawełczyk K, Maciejczyk A, Pudełko M, Kołodziej J, Zabel M, Murawa D, Drag M, Gansukh T, Dietel M, Lage H. Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer. Anticancer Res 2008; 28: 2967-2974
13. Krysan K, Reckamp KL, Sharma S, Dubinett SM. The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem 2006; 6: 209-220 (Pubitemid 43796639)
14. Kang HK, Lee E, Pyo H, Lim SJ. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol Cancer Ther 2005; 4: 1358-1363 (Pubitemid 40879942)